Sarepta Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

Rhea-AI Summary

Sarepta Therapeutics (NASDAQ:SRPT) announced participation in a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022, at 10:00 a.m. P.T. The event will take place at the Terranea Resort, Rancho Palos Verdes, CA. This presentation will be webcast live and archived for 90 days for investor access. Sarepta focuses on developing precision genetic medicine and has over 40 programs in various stages for rare diseases, especially in Duchenne Muscular Dystrophy (DMD).

CAMBRIDGE, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on Tuesday June 14, 2022 at 10:00 a.m. P.T./ 1:00 p.m. E.T. The fireside chat will be held at the Terranea Resort, Rancho Palos Verdes, CA.

The presentation will be webcast live under the Events & Presentations section of the investor relations section of Sarepta’s website at https://investorrelations.sarepta.com/events-presentations and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

Source: Sarepta Therapeutics, Inc.

Investor Contact:
Ian Estepan, 617-274-4052
iestepan@sarepta.com

Media Contact:
Tracy Sorrentino, 617-301-8566
tsorrentino@sarepta.com 

 

FAQ

When is Sarepta Therapeutics participating in the Goldman Sachs Conference?

Sarepta Therapeutics will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022, at 10:00 a.m. P.T.

Where is the Goldman Sachs Conference taking place?

The conference will be held at the Terranea Resort, Rancho Palos Verdes, CA.

How can I watch Sarepta Therapeutics' presentation at the Goldman Sachs Conference?

The presentation will be webcast live on Sarepta's investor relations website and archived for 90 days.

What is the focus of Sarepta Therapeutics in genetic medicine?

Sarepta Therapeutics focuses on precision genetic medicine for rare diseases, particularly Duchenne Muscular Dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs).

How many programs does Sarepta Therapeutics have in development?

Sarepta currently has more than 40 programs in various stages of development.